Optogenetics molecular probes, gene delivery, functional imaging

Nanoscope Technologies specializes in advanced imaging and therapeutic solutions, focusing on the development of innovative technologies for the treatment of retinal diseases. Their flagship product, the Nanoscope, utilizes a unique approach to restore vision by employing a combination of gene therapy and optogenetics. This technology enables the stimulation of remaining retinal cells in patients with degenerative conditions, allowing them to perceive visual information. The company is dedicated to enhancing the quality of life for individuals suffering from vision loss through its cutting-edge research and product pipeline.

In addition to its core vision restoration technology, Nanoscope Technologies is also engaged in the exploration of various applications in the field of nanotechnology. Their research encompasses the development of nanoscale materials and devices that can be utilized in medical diagnostics and therapeutics. By leveraging the unique properties of nanomaterials, the company aims to create more effective treatment options and improve the overall efficacy of existing therapies. Nanoscope Technologies is committed to pushing the boundaries of science and technology to address unmet medical needs in the realm of vision and beyond.

United States

Nanoscope Technologies was founded in 2009 with an objective to develop new methods and devices for scientific, industrial and biomedical applications. Nanoscope has developed a range of biomedical technologies which include diagnostics and therapeutic devices and molecules. These have already generated interest from several clinicians, industries and leaders. We strive to translate the technology to market and bedside.

Nanoscope Technologies

Company Details